A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice Article

Kassa, Jiri, Karasova, Jana, Bajgar, Jiri et al. (2009). A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice . 24(4), 1040-1044. 10.1080/14756360802608419

Open Access

cited authors

  • Kassa, Jiri; Karasova, Jana; Bajgar, Jiri; Kuca, Kamil; Musilek, Kamil; Kopelikova, Irena

sustainable development goals

authors

publication date

  • August 1, 2009

webpage

keywords

  • (E)-BUT-2-ENE LINKER
  • ANTIDOTAL TREATMENT
  • Biochemistry & Molecular Biology
  • COMPOUNDS BEARING
  • CURRENTLY AVAILABLE OXIMES
  • Chemistry, Medicinal
  • H OXIMES
  • HI-6
  • IN-VIVO METHODS
  • K250
  • K251
  • Life Sciences & Biomedicine
  • NERVE AGENTS
  • OBIDOXIME
  • ORGANOPHOSPHORUS COMPOUNDS
  • PARAOXON-INHIBITED ACETYLCHOLINESTERASE
  • Pharmacology & Pharmacy
  • Science & Technology
  • inhibited acetylcholinesterase
  • obidoxime
  • reactivation
  • tabun
  • trimedoxime

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 1040

end page

  • 1044

volume

  • 24

issue

  • 4